GDF3 and obesity due to melanocortin 4 receptor deficiency: Given ALK7′s pivotal role in lipid metabolism and fat mass regulation, the GDF3-ALK7 signaling axis is considered a potential therapeutic target for obesity and associated diabetes [45].